Hyperpolarised 3He ventilation-MRI, anatomical lung MRI, lung clearance index (LCI), low-dose CT and spirometry were performed on 19 children (6–16 years) with clinically stable mild cystic fibrosis (CF) (FEV1>−1.96), and 10 controls. All controls had normal spirometry, MRI and LCI. Ventilation-MRI was the most sensitive method of detecting abnormalities, present in 89% of patients with CF, compared with CT abnormalities in 68%, LCI 47% and conventional MRI 22%. Ventilation defects were present in the absence of CT abnormalities and in patients with normal physiology, including LCI. Ventilation-MRI is thus feasible in young children, highly sensitive and provides additional information about lung structure–function relationships.
- Imaging/CT MRI etc
- Cystic Fibrosis
- Respiratory Measurement
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Lung ventilation heterogeneity due to the obstruction of small airways is an early and potentially reversible step in the progression of cystic fibrosis (CF). Individually, multiple breath washout (MBW), hyperpolarised (HP) gas ventilation-MRI and conventional structural lung imaging by CT have all been shown to be sensitive to early changes in the lungs before spirometry.1–3 The information they provide is complementary, and HP ventilation-MRI in particular has the potential to reveal airways obstruction and the functional consequences of regional structural changes detected with CT, as well as the nature of ventilation heterogeneity that prolongs gas washout in MBW.4 The aim of this study was to investigate the relative sensitivity of imaging and physiology assessments for the detection of early-stage lung disease in children with CF. In addition, we explored what insight functional ventilation imaging provides about the nature of ventilation abnormalities in the lungs in early CF and how these correlate with the more clinically scalable assessment of ventilation heterogeneity provided by MBW.
For full technical details, see the online supplement.
Nineteen CF children and ten controls were assessed. Subjects attended on a single occasion, when clinically stable, and were assessed with SF6 MBW,1 plethysmography, spirometry, HP 3He MRI and 1H MRI. Patients with CF also underwent inspiratory and expiratory chest CT.5 All subjects had FEV1 z-score>−1.96 and were aged between 6 and 16 years old. To test for significant differences between the healthy control and CF patient groups, two-tailed paired tests were performed to reflect the age-matching of data. Sensitivity was defined as the presence of an abnormal measurement (ie, not within the normal range for that measurement) in the presence of the diagnosis of CF. This assumes that all patients should have some abnormality in at least one measurement, which may not be true in this population with very mild clinical expression of CF, and therefore provides a conservative estimation of sensitivity of the lung assessments. This study was approved by the National Research and Ethics Committee (REC 12/YH/0343) and parents/guardians provided written informed consent.
Full demographic and outcome data are presented in the online supplement. Patients with CF had early-stage lung disease, with no significant differences between CF and controls for any lung function measures except lung clearance index (LCI) (figure 1). In controls, no ventilation or structural abnormalities were detected on either 3He or 1H MRI (see online supplement). Both 3He MRI quantitative measures were however significantly increased in patients with CF when compared with controls (figure 1). Ventilation heterogeneity and obstruction seen with ventilation-MRI generally corresponded to anatomical abnormalities detected by CT (see online supplementary figure S4). In several instances, however, ventilation defects were present on ventilation-MRI with no corresponding features of structural pathology detectable on CT (figure 2).
The presence of visible defects on ventilation-MRI had the greatest sensitivity for detecting evidence of CF airways disease: nine patients with CF (47%) had elevated sitting LCI, when compared with 17 (89%) with ventilation-MRI abnormalities. In contrast, structural abnormalities were detectable in four patients (22%) with 1H MRI and 13 patients (68%) with CT. Ventilation-MRI detected abnormalities in four patients with normal CT; LCI was abnormal in only two of these. Two patients with mild variant disease (both R117H-7T heterozygotes) had no abnormality detected by any technique; these were the only patients with CF where 3He MRI was normal.
A table of correlations is presented in the online supplement. LCI and 3He MRI metrics showed significant moderate correlation and 3He MRI %-unventilated lung correlated significantly with CT Brody score and CT gas-trapping score. There was no significant correlation between LCI and CT scores.
This is the first study to combine the powerful functional technique of ventilation imaging using HP gas MRI with assessments of structural lung disease from CT and the whole lungs assessment of ventilation heterogeneity provided by MBW. Although both 3He MRI and MBW measure aspects of ventilation heterogeneity in the lungs, the detailed spatial information provided by ventilation-MRI meant that abnormalities in ventilation distribution were visible even when these were insufficient to affect the LCI. Likewise, ventilation defects were visible in some cases in the absence of structural abnormalities on CT (eg, figure 2), which may be due to the inherent sensitivity of ventilation imaging to small airways obstruction that cannot be explicitly resolved on CT.
These are important findings for our understanding of how CF lung disease develops and how we interpret lung function data. In this cohort of patients with CF, specifically selected to represent those with the mildest airways disease, LCI was abnormal in almost half of all subjects (47%), in keeping with prior observations.1 ,6 Ventilation-MRI however was more sensitive than both LCI and CT and detected ventilation defects in all but two patients (89%), both of whom had genetic variants that may not be associated with CF lung disease until adulthood. The great advantage of ventilation-MRI is that it offers detailed regional information about the nature and distribution of ventilation defects. Thus, in patients with early disease, we predominantly detected patchy ventilation defects distributed throughout the lung, with larger focal defects in areas where there was already evidence of structural damage on CT or 1H MRI. In contrast, MBW represents a washout signal integrated over the whole lungs, so that mild ventilation heterogeneity can inevitably be masked, and differentiation of the signal into regional or anatomical lung compartments is at best speculative.7
The 1H MRI protocol deployed here was used to determine lung boundaries and was not optimised for structural imaging, where new methods such as 3D ultrashort echo time imaging should offer improvements. Alternative CT scoring systems and protocols also exist that may offer additional sensitivity.8 Finally, we did not perform gadolinium contrast-enhanced imaging, as we felt this would deter children from participating. Despite possible limitations in the 1H MRI and CT protocol, it is clear that HP gas ventilation-MRI is a powerful tool for detecting early lung changes. The superior sensitivity and detail of information provided by ventilation-MRI also offers the prospect that this measurement will allow an earlier or more detailed radiation-free appreciation of the response to novel therapies than even LCI.9 The advent of high-quality HP gas ventilation-MRI using the cheaper and readily available 129Xe isotope means that the technology is now much more readily clinically deployed.10 The ventilation-MRI presented here are thus exemplars of what may become routine assessments in detecting early disease and treatment effects.
In conclusion, in this population of children with CF with very mild lung disease, we have shown that ventilation-MRI is highly sensitive to detecting the consequences of airway disease. Even patients with apparently pristine lungs by all current physiology and imaging standards have evidence of ventilation-MRI abnormalities. HP gas MRI provides detailed regional information about disease severity and physiological impairment.
The authors are grateful to all the volunteers and their parents who took part in this research. The authors would like to personally thank Dr Noreen West, Dr Sonal Kansra and the CF team at Sheffield Children's Hospital, Leanne Armstrong for coordination of study visits and Karen O'Donnell for spirometry and plethysmography data acquisition in some subjects.
Helen Marshall and Alex Horsley are joint first authors.
Contributors HM: MRI acquisition and analysis, overall data analysis, co-wrote the manuscript. AH: study design, MBW set-up and over-read of analysis, co-wrote the manuscript. CJT: study design, patient recruitment, reviewed the manuscript. LS: performed and analysed lung function and MBW measurements, reviewed the manuscript. DH: scored CT images and reviewed all MRI, reviewed the manuscript. FCH: performed MBW measurements, MRI acquisition, reviewed the manuscript. AJS: scored CT images, reviewed the manuscript. JP-R: polarised gas. PJH: MR image registration. GN, NJS and GJC: polarised gas, technical imaging support. DT: statistical support. SC: study design, reviewed the manuscript. IA: patient recruitment and consent, reviewed the manuscript. JMW: study design, MRI acquisition design, data analysis, co-wrote the manuscript, underwrites the work. The corresponding author had access to all the data in the study and accepts responsibility for its validity.
Funding This article presents independent research funded by the Cystic Fibrosis Trust and the National Institute of Health Research (NIHR).
Disclaimer The funders had no role in the study design, data collection, analysis, interpretation or preparation of this report. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
Competing interests None declared.
Patient consent Obtained.
Ethics approval National Research and Ethics Committee.
Provenance and peer review Not commissioned; externally peer reviewed.